Brief: XORTX Therapeutics Announces Submission Of Clinical Trial Application To Conduct Bridging Pharmacokinetics Study
14/03/2022 11:22
March 14 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX THERAPEUTICS ANNOUNCES SUBMISSION OF CLINICAL TRIAL
APPLICATION TO CONDUCT BRIDGING PHARMACOKINETICS STUDY
Source text for Eikon: ID:nGNX487Dpy
Further company coverage: XRTX.V
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM